Determinants of Health-related Quality of Life in People with Human Immunodeficiency Virus, Failing First-line Treatment in Africa

Overview

Journal Health Qual Life Outcomes

Publisher Biomed Central

Specialty Public Health

Date 2023 Aug 22

PMID 37605150

Authors

Tamlyn A Rautenberg

Shu Kay Ng

Gavin George

Mahomed-Yunus S Moosa

Suzanne M McCluskey

Rebecca F Gilbert

Selvan Pillay

Isaac Aturinda

Kevin L Ard

Winnie R Muyindike

Nicholas Musinguzi

Godfrey Masette

Melendhran Pillay

Pravi Moodley

Jaysingh Brijkumar

Rajesh T Gandhi

Brent Johnson

Henry Sunpath

Mwebesa B Bwana

Vincent C Marconi

Mark J Siedner

Affiliations

Soon will be listed here.

Abstract

Background: Antiretroviral treatment improves health related quality of life (HRQoL) of people with human immunodeficiency virus (PWH). However, one third initiating first-line treatment experience virological failure and the determinants of HRQoL in this key population are unknown. Our study aims to identify determinants of among PWH failing antiretroviral treatment in sub-Saharan Africa.

Methods: We analysed data from a cohort of PWH having virological failure (> 1,000 copies/mL) on first-line ART in South Africa and Uganda. We measured HRQoL using the EuroQOL EQ-5D-3L and used a two-part regression model to obtain by-country analyses for South Africa and Uganda. The first part identifies risk factors that were associated with the likelihood of participants reporting perfect health (utility = 1) versus non-perfect health (utility < 1). The second part identifies risk factors that were associated with the EQ-5 L-3L utility scores for participants reporting non-perfect health. We performed sensitivity analyses to compare the results between the two-part model using tobit models and ordinary least squares regression.

Results: In both countries, males were more likely to report perfect health and participants with at least one comorbidity were less likely to report perfect health. In South Africa, participants with side effects and in Uganda those with opportunistic infections were also less likely to report perfect health. In Uganda, participants with 100% ART adherence were more likely to report perfect health. In South Africa, high HIV viral load, experiencing ART side effects, and the presence of opportunistic infections were each associated with lower HRQoL, whereas participants with 100% ART adherence reported higher HRQoL. In Uganda participants with lower CD4 count had lower HRQoL.

Conclusion: Markers of advanced disease (opportunistic infection, high viral load, low CD4), side effects, comorbidities and lack of ART adherence negatively impacted HRQoL for PWH experiencing virological failure.

Trial Registration: ClinicalTrials.gov: NCT02787499.

References

Thomas R, Burger R, Harper A, Kanema S, Mwenge L, Vanqa N . Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial. Lancet Glob Health. 2017; 5(11):e1133-e1141. PMC: 5640509. DOI: 10.1016/S2214-109X(17)30367-4. View

Bigna J, Plottel C, Koulla-Shiro S . Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count. Infect Dis Poverty. 2016; 5(1):85. PMC: 5011352. DOI: 10.1186/s40249-016-0179-9. View

Jamieson D, Kellerman S . The 90 90 90 strategy to end the HIV Pandemic by 2030: Can the supply chain handle it?. J Int AIDS Soc. 2016; 19(1):20917. PMC: 4930545. DOI: 10.7448/IAS.19.1.20917. View

Barth R, Schim van der Loeff M, Schuurman R, Hoepelman A, Wensing A . Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. Lancet Infect Dis. 2010; 10(3):155-66. DOI: 10.1016/S1473-3099(09)70328-7. View

Jelsma J, Maclean E, Hughes J, Tinise X, Darder M . An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS Care. 2005; 17(5):579-88. DOI: 10.1080/09540120412331319714. View

Louwagie G, Bachmann M, Meyer K, Booysen F, Fairall L, Heunis C . Highly active antiretroviral treatment and health related quality of life in South African adults with human immunodeficiency virus infection: A cross-sectional analytical study. BMC Public Health. 2007; 7:244. PMC: 2194770. DOI: 10.1186/1471-2458-7-244. View

Nglazi M, West S, Dave J, Levitt N, Lambert E . Quality of life in individuals living with HIV/AIDS attending a public sector antiretroviral service in Cape Town, South Africa. BMC Public Health. 2014; 14:676. PMC: 4227123. DOI: 10.1186/1471-2458-14-676. View

Mutabazi-Mwesigire D, Katamba A, Martin F, Seeley J, Wu A . Factors That Affect Quality of Life among People Living with HIV Attending an Urban Clinic in Uganda: A Cohort Study. PLoS One. 2015; 10(6):e0126810. PMC: 4454695. DOI: 10.1371/journal.pone.0126810. View

Tran B, Ohinmaa A, Nguyen L . Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients. Health Qual Life Outcomes. 2012; 10:132. PMC: 3541089. DOI: 10.1186/1477-7525-10-132. View

10.

Mokgethi N, Christofides N, Machisa M, Akpomiemie G, Lalla-Edward S . Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa. BMC Infect Dis. 2022; 22(1):456. PMC: 9103409. DOI: 10.1186/s12879-022-07429-9. View

11.

Keaei M, Kuhlmann J, Conde R, Evers S, Gonzalez J, Govers M . Health-Related Quality of Life of Patients with HIV/AIDS in Bogotá, Colombia. Value Health Reg Issues. 2016; 11:68-72. DOI: 10.1016/j.vhri.2016.05.001. View

12.

Zhou T, Guan H, Wang L, Zhang Y, Rui M, Ma A . Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review. Front Public Health. 2021; 9:675523. PMC: 8275935. DOI: 10.3389/fpubh.2021.675523. View

13.

Reynolds Z, McCluskey S, Moosa M, Gilbert R, Pillay S, Aturinda I . Who's slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first-line HIV treatment in Uganda and South Africa. HIV Med. 2021; 23(5):474-484. PMC: 9010349. DOI: 10.1111/hiv.13203. View

14.

Mihaylova B, Briggs A, OHagan A, Thompson S . Review of statistical methods for analysing healthcare resources and costs. Health Econ. 2010; 20(8):897-916. PMC: 3470917. DOI: 10.1002/hec.1653. View

15.

Wu M, Brazier J, Kearns B, Relton C, Smith C, Cooper C . Examining the impact of 11 long-standing health conditions on health-related quality of life using the EQ-5D in a general population sample. Eur J Health Econ. 2014; 16(2):141-51. PMC: 4339694. DOI: 10.1007/s10198-013-0559-z. View

16.

Wong E, Xu R, Wai Ling Cheung A . Health-related quality of life among patients with hypertension: population-based survey using EQ-5D-5L in Hong Kong SAR, China. BMJ Open. 2019; 9(9):e032544. PMC: 6773333. DOI: 10.1136/bmjopen-2019-032544. View

17.

Sauzet O, Razum O, Widera T, Brzoska P . Two-Part Models and Quantile Regression for the Analysis of Survey Data With a Spike. The Example of Satisfaction With Health Care. Front Public Health. 2019; 7:146. PMC: 6579824. DOI: 10.3389/fpubh.2019.00146. View

18.

Siedner M, Moosa M, McCluskey S, Gilbert R, Pillay S, Aturinda I . Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa : An Unblinded Randomized Controlled Trial. Ann Intern Med. 2021; 174(12):1683-1692. PMC: 8688215. DOI: 10.7326/M21-2229. View

19.

Bhargava A, Booysen F . Healthcare infrastructure and emotional support are predictors of CD4 cell counts and quality of life indices of patients on antiretroviral treatment in Free State Province, South Africa. AIDS Care. 2010; 22(1):1-9. DOI: 10.1080/09540120903012585. View

20.

Mwesigire D, Martin F, Seeley J, Katamba A . Relationship between CD4 count and quality of life over time among HIV patients in Uganda: a cohort study. Health Qual Life Outcomes. 2015; 13:144. PMC: 4570610. DOI: 10.1186/s12955-015-0332-3. View